Industry
Biotechnology
Generation Bio Co., a genetic medicines company, develops therapies for the treatment of rare and prevalent diseases. The company provides a portfolio of programs, including programs for rare and prevalent diseases of the liver and retina. It also focuses on the diseases of skeletal muscle, central nervous system, and oncology. The company was formerly known as Torus Therapeutics, Inc. and changed its name to Generation Bio Co. in November 2017. Generation Bio Co. was incorporated in 2016 and is headquartered in Cambridge, Massachusetts.
Loading...
Open
N/A
Mkt cap
N/A
Volume
N/A
High
N/A
P/E Ratio
N/A
52-wk high
N/A
Low
N/A
Div yield
N/A
52-wk low
N/A
Portfolio Pulse from Benzinga Newsdesk
March 07, 2024 | 1:18 pm
Portfolio Pulse from Benzinga Newsdesk
March 07, 2024 | 11:46 am
Portfolio Pulse from Happy Mohamed
March 06, 2024 | 9:40 pm
Portfolio Pulse from Benzinga Insights
December 01, 2023 | 5:31 pm
Portfolio Pulse from Benzinga Newsdesk
November 29, 2023 | 12:01 pm
Portfolio Pulse from Benzinga Newsdesk
November 29, 2023 | 12:00 pm
Portfolio Pulse from Benzinga Newsdesk
November 10, 2023 | 1:55 pm
Portfolio Pulse from Benzinga Newsdesk
November 09, 2023 | 11:40 pm
Portfolio Pulse from Benzinga Newsdesk
October 26, 2023 | 11:24 am
All corporate logos and prices are for illustrative purposes only and are not a recommendation, an offer to sell, or a solicitation of an offer to buy any security.